Options unfairly limited for off-label Medicare dermatology treatments

February 4, 2019

Dr. Adam Friedman, Professor and Interim Chair of Dermatology, calls for dermatologists to "step up to the off-label challenge." Dr. Friedman reasons that dermatologists should be more included in the decision about what medications are covered and what are not. Read more by clicking the link.